Ingestion of creatine monohydrate immediately prior to exercise does not increase performance in creatine loaded individuals

C. Earnest, B. O. Whyte, V. Ben-Ezra, A. Almada, S. Beckham
{"title":"Ingestion of creatine monohydrate immediately prior to exercise does not increase performance in creatine loaded individuals","authors":"C. Earnest, B. O. Whyte, V. Ben-Ezra, A. Almada, S. Beckham","doi":"10.1080/15438620009512561","DOIUrl":null,"url":null,"abstract":"Twenty‐four participants (15 men; 9 women) performed baseline testing (day 1) after following a standard unsupplemented diet. This was followed by the daily ingestion of a creatine formulation dietary loading sequence for 5 days (days 2–6, Phosphagen HP™ 5.25 g creatine mono‐hydrate (CR) 4‐ 33 g dextrose). Loading consisted of 4 servings of Phosphagen HP™ per day. On day 7, participants were randomly assigned to one of three double‐blind treatments administered 1 h before testing. During treatment, subjects were randomly fed: (a) 10 g of CR, (b) 80 g of dextrose, or (c) 10 g of CR + 80 g of dextrose. Variables evaluating the effectiveness of the different regimens included body mass, two 30‐s Wingate anaerobic performance power tests and measurement of serum creatine concentration 65 and 5 min before each trial. Plasma ammonia concentration was also measured 65 min before and 5 min after each trial. The results of this trial show a significant non‐placebo controlled effect for the pooled, group and gender data (P ≤ 0.05). Following 5 days of Phosphagen HP™ loading, significant pooled group mean changes were: (1) body mass (+1.08 kg), (2) anaerobic power (1st Wingate = + 1.28 kJ; 2nd Wingate 2 = (+1.92kJ), (3) serum creatine concentration 65 min prior to testing trials (+624.06 μmol · L−1) and (4) post‐test plasma ammonia concentration (—83.63 μmol · L−1). However, on day 7, in placebo group condition, no between group performance effects were noted following an acute 10 g oral bolus of CR 1 h prior to the exercise test. It is concluded that no performance benefit is due to acute ingestion of CR 1 h before exercise in CR loaded individuals.","PeriodicalId":403174,"journal":{"name":"Sports Medicine, Training and Rehabilitation","volume":"50 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2000-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sports Medicine, Training and Rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15438620009512561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Twenty‐four participants (15 men; 9 women) performed baseline testing (day 1) after following a standard unsupplemented diet. This was followed by the daily ingestion of a creatine formulation dietary loading sequence for 5 days (days 2–6, Phosphagen HP™ 5.25 g creatine mono‐hydrate (CR) 4‐ 33 g dextrose). Loading consisted of 4 servings of Phosphagen HP™ per day. On day 7, participants were randomly assigned to one of three double‐blind treatments administered 1 h before testing. During treatment, subjects were randomly fed: (a) 10 g of CR, (b) 80 g of dextrose, or (c) 10 g of CR + 80 g of dextrose. Variables evaluating the effectiveness of the different regimens included body mass, two 30‐s Wingate anaerobic performance power tests and measurement of serum creatine concentration 65 and 5 min before each trial. Plasma ammonia concentration was also measured 65 min before and 5 min after each trial. The results of this trial show a significant non‐placebo controlled effect for the pooled, group and gender data (P ≤ 0.05). Following 5 days of Phosphagen HP™ loading, significant pooled group mean changes were: (1) body mass (+1.08 kg), (2) anaerobic power (1st Wingate = + 1.28 kJ; 2nd Wingate 2 = (+1.92kJ), (3) serum creatine concentration 65 min prior to testing trials (+624.06 μmol · L−1) and (4) post‐test plasma ammonia concentration (—83.63 μmol · L−1). However, on day 7, in placebo group condition, no between group performance effects were noted following an acute 10 g oral bolus of CR 1 h prior to the exercise test. It is concluded that no performance benefit is due to acute ingestion of CR 1 h before exercise in CR loaded individuals.
运动前立即摄入一水肌酸不会提高肌酸负荷个体的表现
24名受试者(15名男性;9名妇女)在遵循标准无补充饮食后进行基线测试(第1天)。随后连续5天每天摄入肌酸配方膳食负荷序列(第2-6天,磷酸根HP™5.25 g肌酸单水(CR) 4 - 33 g葡萄糖)。每天加载4份磷酸根HP™。在第7天,参与者在测试前1小时被随机分配到三种双盲治疗中的一种。在治疗期间,受试者被随机喂食:(a) 10 g CR, (b) 80 g葡萄糖,或(c) 10 g CR + 80 g葡萄糖。评估不同方案有效性的变量包括体重、两次30 s Wingate无氧性能测试以及每次试验前65分钟和5分钟血清肌酸浓度的测量。测定每次试验前65 min和试验后5 min血氨浓度。该试验的结果显示,合并、分组和性别数据均存在显著的非安慰剂对照效应(P≤0.05)。在5天的磷素HP™负荷后,显著的合并组平均变化为:(1)体重(+1.08 kg),(2)厌氧能力(第1 Wingate = + 1.28 kJ;2 Wingate 2 = (+1.92kJ),(3)试验前65 min血清肌酸浓度(+624.06 μmol·L−1),(4)试验后血浆氨浓度(-83.63 μmol·L−1)。然而,在第7天,在安慰剂组的情况下,在运动试验前1小时急性口服10g CR后,没有发现组间表现的影响。由此得出结论,在运动前1小时急性摄入CR对运动成绩没有好处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信